2019 BIO INTERNATIONAL CONVENTION EVENT SUMMARY

JUNE 3-6, 2019 • PHILADELPHIA, PA • #BIO2019

IT STARTS WITH NE

convention.bio.org

1,800+ EXHIBITORS

46 DOMESTIC

+ INTERNATIONAL PAVILIONS

75 ORGANIZATIONS

IN THE BIO PATIENT ADVOCACY PAVILION

800+ SPEAKERS

150+ SESSIONS

18 EDUCATION

TRACKS

250+ COMPANY

PRESENTATIONS

16 SUPER SESSIONS

AND FIRESIDE CHATS

50 START-UP STADIUM

PRESENTERS

including Company Presentations + Start-Up Stadium participants

48,500+ PARTNERING MEETINGS BETWEEN

7,796 DELEGATES

FROM

4,102 COMPANIES

BIO 2019 by the Numbers

17,307 ATTENDEES

FROM

65 COUNTRIES

49 STATES, DC, AND PUERTO RICO

8,400+ COMPANIES

25% FIRST TIME ATTENDEES

100+ INTERNATIONAL AND US

PUBLIC OFFICIALS

153 STUDENT DAY PARTICIPANTS

convention.bio.org

BREAKDOWN BY TITLE

24% CEO/C-Level23% VP/Partner/Managing Director44% Director/Mid-Level Manager5% Coordinator2% Educator/University Faculty/Students2% Public Official/Foreign Minister

44%

24%

23%

5%

2% 2%

Attendance History

15,667ATTENDEES

2014SAN DIEGO

15,858ATTENDEES

2015PHILADELPHIA

16,123ATTENDEES

2017SAN DIEGO

18,289ATTENDEES

2018BOSTON

17,307ATTENDEES

2019PHILADELPHIA

15,937ATTENDEES

2016SAN FRANCISCO

4,366FIRST TIME ATTENDEES

IN 2019 (24%)

convention.bio.org

COMPANY SIZE (Based on number of employees)

PRIMARY JOB ROLE OF ATTENDEES

27% Executive42% Business Development/Sales10% Researcher/ Scientist6% Consulting Services5% Attorney/General Counsel/Associate5% Policy/Government Affairs/Advocacy5% Marketing/PR

Top 10 COMPANY TYPES REPRESENTED

1. Clinical

2. Market – Drug (on patent)

3. Preclinical

4. Consulting

5. Legal

6. University (Faculty)

7. Research Institute

8. Research Technology

9. CRO & Analytical Labs

10. Tech Transfer

Attendee Stats

PURCHASE INFLUENCE

42%

1 – 50

8%

51 – 100

11%

101 – 300

7%

301 – 500

32%

500+

61% OF ATTENDEES HAVE INFLUENCE OVER PURCHASES MADE FOR THEIR COMPANY

42%

27%

10%

6%5%

5%5%

convention.bio.org

International Attendee Stats

1 Canada

2 South Korea

3 United Kingdom

4 Japan

5 Germany

6 China

7 Taiwan

8 France

9 Australia

10 Brazil

65COUNTRIES

49STATES

38%OF ATTENDEES ARE

INTERNATIONAL

TOP 10 INTERNATIONAL DELEGATIONS

EVALUATE products/services for

purchase or investment

SEARCH for new/emerging

technologies

ATTEND company presentations and education sessions

TOP REASONS to Attend BIO

NETWORK & PARTNER with attendees and exhibitors

48,500

Partnering Activity Has

Grown 66% in the last 5 years

World's Largest Biotech

Partnering Event

WORLD'S LARGEST BIOTECH PARTNERING EVENT

7,796

4,102

convention.bio.org

NUMBER OF MEETINGS

NUMBER OF COMPANIES

NUMBER OF DELEGATES

BIO One-on-One PartneringTM

PHILADELPHIA SAN FRANCISCO SAN DIEGO BOSTON PHILADELPHIA

convention.bio.org

ACADEMIC CAMPUS

FEATURED UNIVERSITIES AND RESEARCH INSTITUTIONS

San Diego Innovation Council

21 UNIVERSITIES

124 TOTAL PARTICIPANTS

800+ SPEAKERS

150+ SESSIONS

18 EDUCATION

TRACKS

250+ COMPANY

PRESENTATIONS

16 SUPER SESSIONS

AND FIRESIDE CHATS

50 START-UP STADIUM

PRESENTERS

including Company Presentations + Start-Up Stadium participants

convention.bio.org

Education Program – Education Tracks

BIOFUELS & RENEWABLE CHEMICALS TRACK BRAIN HEALTH TRACK BUSINESS DEVELOPMENT &

FINANCE TRACK

DIGITAL HEALTH TRACK EMERGING OPPORTUNITIES IN GLOBAL MARKETS TRACK

GENOME EDITING TRACK HIGHLY PREVALENT CHRONIC DISEASES TRACK – NEW!

INFECTIOUS DISEASES & VACCINES TRACK

INTELLECTUAL PROPERTY TRACK

NEXT GENERATION BIOTHERAPEUTICS TRACK

ONCOLOGY TRACK

OPIOIDS: CHANGING THE PARADIGM ON TREATING PAIN

ORPHAN & RARE DISEASES TRACK

PATIENT ADVOCACY TRACK – NEW!

PERSONALIZED MEDICINE & DIAGNOSTICS TRACK

REGULATORY INNOVATION TRACK

TRANSLATIONAL RESEARCH TRACK

VALUE, PATIENT ACCESS, & COMMERCIALIZATION TRACK

What’s Next: The Landscape of Innovation in 2019 and Beyond

Digital Health in Practice: A Conversation with Ameet Nathwani, Chief Digital Officer, Chief Medical Officer and Member of the Executive Committee, Sanofi

Falling in Love with Science: Championing Science for Everyone, Everywhere

Biotech’s Contribution to Innovation: Current and Future Drivers of Success

Realizing the Promise of Gene Therapies for Patients Around the World

Dealmakers’ Intentions: 2019 Market Outlook

The Art & Science of R&D Innovation and Productivity

The State of the Vaccine Industry: Stimulating Sustainable Growth

Nature Biotechnology and Scientific American WORLDVIEW: Biotech Innovation in a Faster Future

convention.bio.org

Education Program – Super Sessions

convention.bio.org

Peter Marks, MD, PhDDirector of the Center for Biologics Evaluation and Research (CBER) at U.S. Food and Drug Administration

John MaraganoreChief Executive Officer at Alnylam Pharmaceuticals

Janet Woodcock, MDDirector of the Center for Drug

Evaluation and Research (CDER) at U.S. Food And Drug Administration (FDA)

Jeffrey SolomonChief Executive Officer at COWEN

Jeremy LevinCEO, Chairman at Ovid Therapeutics

Norman Sharpless, MDActing Commissioner,

US Food & Drug Administration

Christi ShawSenior Vice President and President,

Lilly BIO-Medicines, Eli Lilly and Company

Meg TirrellBiotech and Pharma Reporter at CNBC

Kenneth C. FrazierChairman of the Board and Chief

Executive Officer at Merck & Co, Inc.

Julie Gerberding, MD, PhDExecutive Vice President & Chief

Patient Officer at Merck & Co, Inc.

Christopher AnselmoMarket Intelligence Manager at Muscular Dystrophy Association

Eve BukowskiVice President, Patient Advocacy,

Education & Outreach atCalifornia Life Sciences Association (CLSA)

Emily Kramer-GolinkoffCo-Founder at Emily’s Entourage

Margaret (Peggy) Hamburg, MDForeign Secretary, National Academy

of Medicine at Chairman of the Board, American Association for the

Advancement of Science

Education Program – Fireside Chat Speakers

convention.bio.org

Next Generation Biotherapeutics

Business Development & Finance

Oncology

What’s Next: The Landscape of Innovation in 2019 and Beyond

Gene Therapy 2.0: No Longer Science Fiction

Fireside Chat with Kenneth C. Frazier, Chairman of the Board and Chief Executive Officer, Merck & Co., Inc.

Dealmakers’ Intentions: 2019 Market Outlook

Top 3 Attended TracksTop 4 Attended Sessions

Education Program

convention.bio.org

Education Program – Diversity of Experts

Maina BhamanPartner, Capital Funds

Sofinnova Partners

Roger ConnorPresident, GSK Vaccines

GlaxoSmithKline

Debra MillerChief Executive Officer

and Founder CureDuchenne

Seema KumarVice President, Innovation, Global Health

and Policy Communication Johnson & Johnson Innovation (Moderator)

Neel PatelManaging Director,

Portfolio & Commercial Strategy Syneos Health

(Moderator & Presenter)

Sam UlinManaging Director

ClearView Healthcare Partners

Ameet NathwaniChief Digital Officer, Chief Medical Officer

and Member of the Executive Committee Sanofi

Saurabh SahaSenior Vice President R&D,

Global Head of Translational Medicine Bristol-Myers Squibb

Stacy LindleyVice President and Head of Emerging Biopharma

Alliance Management, IQVIA Biotech (Moderator)

convention.bio.org

2018Robin Roberts

Rob Reiner

2017David CameronAnn Romney

2016Will Smith

Dr. Benet Omalu

2015Tom Brokaw

Eric TopolWynton Marsalis

2014Hillary Clinton

Richard Branson

PREVIOUS KEYNOTE SPEAKERS

Siddhartha MukherjeePhysician, Biologist, Oncologist + Author

Jamie DimonChairman & CEO, JP Morgan Chase

Global Finance Leader

BIO 2019 Keynote Speakers

convention.bio.org

BIO ActionBIO Patient

Advocacy Pavilion BioProcess Zone

Contract Services ZoneInnovation Zone

Start-Up Stadium

BIO 2019 FEATURED

OVER 150 NEW EXHIBITORS

1,800+ EXHIBITORS

46DOMESTIC

+ INTERNATIONAL PAVILIONS

75 ORGANIZATIONS

IN THE BIO PATIENT ADVOCACY PAVILION

BIO Exhibition Overview

1 New Zealand

2 Poland

3 Uruguay

4 Welsh Government

4 NEW PAVILIONS

SPECIALTY ZONES & PAVILIONS

convention.bio.org

BIO 2019 Sponsors

DOUBLE HELIX

HELIX

convention.bio.org

BIO 2019 Sponsors

Alkermes

Alnylam Pharmaceuticals

Biogen

Boehringer Ingelheim Pharmaceuticals, Inc.

Chubb

Covance, Inc.

CSL Behring

Daiichi Sankyo

GlaxoSmithKline

IQVIA Biotech

Novartis

Retrophin

Sanofi Pasteur

Servier

Syneos Health

Takeda

VWR, Part of Avantor

Astellas Pharma Inc.

Elanco Animal Health

Foley Hoag LLP

GE Healthcare

Horizon Therapeutics

Inova Software

Locust Walk

Otsuka

Torreya

Abcam

Acceleron Pharma Inc.

Amarin Pharma Inc.

Asahi Kasei Pharma Corporation

BioInnovation Institute

Brii Biosciences

Celgene

City of Phoenix

Clarivate Analytics

Clinical Network Services (CNS) PTY LTD

Cooley LLP

Ferring Pharmaceuticals

Fujifilm Healthcare

Lupin, Inc.

MedChemBio

Pepper Hamilton LLP

Regeneron

Signals Analytics

State Government of Victoria, Australia

Trinity

Wells Fargo

PREMIER CHAMPION CONFERENCE

18

convention.bio.org

• JUNE 8-11, 2020 •

• SAN DIEGO •